Lagaña, Rejohn A.

HRN: 23-17-73  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2023
AMPICILLIN 1GM (VIAL)
06/22/2023
06/29/2023
IV
105mg
Q12
PSNB
Waiting Final Action 
06/22/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
06/22/2023
06/29/2023
IV
11mg
Q24
PSNB
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: